Geron Corporation
Status: Publicly traded
Direct answer
Geron Corporation is publicly traded on NASDAQ under the ticker GERN.
Geron Corporation is an advanced-stage biopharmaceutical company dedicated to the creation and market introduction of treatments for myeloid blood cancers. Its primary drug candidate, imetelstat, is a telomerase inhibitor currently undergoing Phase 3 clinical evaluation. This therapy aims to suppress the unchecked proliferation of cancerous stem and progenitor cells characteristic of myeloid hematologic...
Can you invest in Geron Corporation?
Yes. Geron Corporation is publicly traded on NASDAQ under the ticker GERN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Geron Corporation
Detailed equity research is provided by MarketSnap.